Previous reports have also shown that mut-p53 favors tumorigenic capacities and induces the expression of stem cell markers, such as ALDH1A1, CD44, or Lgr5, in colorectal cancer cells, suggesting an important effect of GOF in this type of disease (Solomon et al. 2018). This evidence concerns the gene TP53 and colorectal cancer.